MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness (FuncProst)
Sponsor: Oslo University Hospital
This observational or N/A phase trial investigates Genital Neoplasms, Male and Prostatic Diseases and is currently ongoing. Oslo University Hospital leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jul 2022 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Mar 2022 — Jul 2022 [monthly]
Recruiting
-
Dec 2021 — Mar 2022 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Nov 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oslo University Hospital
- Radboud University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .